Viscofan - Public Comps and Valuation Multiples

Viscofan Overview

About Viscofan

Viscofan SA is a casing market and offers growth propositions in the food and health sectors outside the traditional business. It engaged in the manufacture, distribution, and marketing of all types of casings and films for food use. Its products include Cellulose, Collagen, Fibrous, Functional solutions, Plastics, Viscofan Veggie, eFAN, and Edileaf. It also manufactures casings, films, and bags obtained through the treatment of plastic polymers. It has a geographic presence in EMEA, APAC, North America, and South America with key revenue generation from EMEA.

Founded

1975

HQ

Employees

5.3K+

Website

viscofan.com

Sectors

Packaging & Containers

Financials

LTM Revenue $1.4B

LTM EBITDA $351M

EV

$3.1B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Viscofan Financials

As of September 2025, Viscofan reported last 12-month revenue of $1.4B and EBITDA of $351M.

In the same period, Viscofan generated $1.0B in LTM gross profit and $183M in net income.

See Viscofan valuation multiples based on analyst estimates

Viscofan P&L

In the most recent fiscal year, Viscofan reported revenue of $1.4B and EBITDA of $348M.

Viscofan expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Viscofan valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$1.4B	XXX	$1.4B	XXX	XXX	XXX
Gross Profit	$1.0B	XXX	$941M	XXX	XXX	XXX
Gross Margin	70%	XXX	68%	XXX	XXX	XXX
EBITDA	$351M	XXX	$348M	XXX	XXX	XXX
EBITDA Margin	24%	XXX	25%	XXX	XXX	XXX
EBIT	$252M	XXX	$234M	XXX	XXX	XXX
EBIT Margin	18%	XXX	17%	XXX	XXX	XXX
Net Profit	$183M	XXX	$182M	XXX	XXX	XXX
Net Margin	13%	XXX	13%	XXX	XXX	XXX
Net Debt	XXX	XXX	$169M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Viscofan including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $1.4B. EBITDA for the last twelve months was $351M. In the most recent fiscal year, Viscofan achieved $1.4B in revenue and $348M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$1.4B	Analyst estimates available to subscribers	$1.4B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$1.0B	Analyst estimates available to subscribers	$941M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	69.6% gross margin	Analyst estimates available to subscribers	67.6% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$351M	Analyst estimates available to subscribers	$348M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	24.3% EBITDA margin	Analyst estimates available to subscribers	25.0% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$252M	Analyst estimates available to subscribers	$234M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	17.5% EBIT margin	Analyst estimates available to subscribers	16.8% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$183M	Analyst estimates available to subscribers	$182M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	12.7% net profit margin	Analyst estimates available to subscribers	13.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$169M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Viscofan

This financial data table provides comprehensive performance metrics for Viscofan, a company based in Spain. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Viscofan generated $1.4B in revenue over the last twelve months.
The company achieved $351M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $1.0B.
Net income over the last twelve months reached $183M.

Fiscal Year Performance

In the most recent fiscal year, Viscofan reported $1.4B in total revenue.
Fiscal year EBITDA was $348M.
The company maintained a gross profit margin of 67.6% in the most recent fiscal year.
EBITDA margin for the fiscal year was 25.0%.
Net profit margin reached 13.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Viscofan. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Viscofan Stock Performance

Viscofan has current market cap of EUR 2.5B (or $2.8B), and EV of EUR 2.7B (or $3.1B).

Market Cap Evolution

Viscofan Stock Data

As of October 17, 2025, Viscofan's stock price is EUR 54 (or $62).

See Viscofan trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$3.1B	$2.8B	XXX	XXX	XXX	XXX	$3.94

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Viscofan Valuation Multiples

Viscofan's trades at 2.2x EV/Revenue multiple, and 8.9x EV/EBITDA.

See valuation multiples for Viscofan and 15K+ public comps

Viscofan Financial Valuation Multiples

As of October 17, 2025, Viscofan has market cap of $2.8B and EV of $3.1B.

Equity research analysts estimate Viscofan's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Viscofan has a P/E ratio of 15.6x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$2.8B	XXX	$2.8B	XXX	XXX	XXX
EV (current)	$3.1B	XXX	$3.1B	XXX	XXX	XXX
EV/Revenue	2.2x	XXX	2.2x	XXX	XXX	XXX
EV/EBITDA	8.9x	XXX	8.9x	XXX	XXX	XXX
EV/EBIT	12.3x	XXX	13.3x	XXX	XXX	XXX
EV/Gross Profit	3.1x	XXX	n/a	XXX	XXX	XXX
P/E	15.6x	XXX	15.7x	XXX	XXX	XXX
EV/FCF	17.8x	XXX	16.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Viscofan Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Viscofan Margins & Growth Rates

Viscofan's last 12 month revenue growth is 5%

Viscofan's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Viscofan's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Viscofan's rule of X is 36% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Viscofan and other 15K+ public comps

Viscofan Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	5%	XXX	4%	XXX	XXX	XXX
EBITDA Margin	24%	XXX	25%	XXX	XXX	XXX
EBITDA Growth	8%	XXX	9%	XXX	XXX	XXX
Rule of 40	26%	XXX	29%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	36%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	0%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	51%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial